Tarsus Pharmaceuticals Inc. (TARS) Statistics & Valuation Metrics - Stocknear

Tarsus Pharmaceuticals In...

NASDAQ: TARS · Real-Time Price · USD
55.39
0.13 (0.24%)
At close: Sep 25, 2025, 3:59 PM
55.39
0.00%
After-hours: Sep 25, 2025, 04:18 PM EDT

Tarsus Pharmaceuticals Statistics

Share Statistics

Tarsus Pharmaceuticals has 42.21M shares outstanding. The number of shares has increased by 10.44% in one year.

42.21M
10.44%
0.98%
99.99%
38.61M
1
n/a

Short Selling Information

The latest short interest is 6.93M, so 16.41% of the outstanding shares have been sold short.

6.93M
16.41%
16.96%
12.99

Valuation Ratios

The PE ratio is -18.02 and the forward PE ratio is 57.35. Tarsus Pharmaceuticals's PEG ratio is 0.54.

-18.02
57.35
11.38
3.8
9.27
-24.61
0.54
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Tarsus Pharmaceuticals.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 4.42, with a Debt / Equity ratio of 0.32.

4.42
4.39
0.32
-0.68
-0.86
-15.36

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$566.42K
$-357.75K
323
0.49
4.9

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 70.66% in the last 52 weeks. The beta is 0.82, so Tarsus Pharmaceuticals's price volatility has been higher than the market average.

0.82
70.66%
50.33
48.14
56.95
672,426

Income Statement

In the last 12 months, Tarsus Pharmaceuticals had revenue of 182.95M and earned -115.55M in profits. Earnings per share was -3.07.

182.95M
170.13M
-120.57M
-115.55M
-106.48M
-108.11M
-3.07
Full Income Statement

Balance Sheet

The company has 94.82M in cash and 72.45M in debt, giving a net cash position of 22.37M.

94.82M
72.45M
22.37M
-360.21M
494.99M
384.18M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -83.03M and capital expenditures -1.57M, giving a free cash flow of -84.59M.

-83.03M
-1.57M
-84.59M
-2.25
Full Cash Flow Statement

Margins

Gross margin is 92.99%, with operating and profit margins of -65.9% and -63.16%.

92.99%
-65.9%
-63.16%
-63.16%
-58.2%
-65.9%
-46.24%

Dividends & Yields

TARS does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for TARS is $66, which is 19.4% higher than the current price. The consensus rating is "Buy".

$66
19.4%
Buy
6
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

8.32
3